Align Technology (ALGN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
9 Aug, 2026Executive summary
Q2 2026 delivered record revenues of $1.06 billion, up 4.3% year-over-year, driven by 8.2% Clear Aligner revenue growth and 7.4% increase in case volume, with double-digit international expansion and stable North America performance.
Systems and Services revenues declined 10.8% year-over-year, reflecting softness in the capital equipment market and a shift to lower-priced scanners and flexible acquisition models.
Non-GAAP operating margin was 22.9%, up 1.6 points year-over-year; GAAP operating margin was 14.6%, impacted by a $37.5 million UK VAT liability.
Net income was $108.3 million (GAAP), with diluted EPS of $1.51; non-GAAP net income was $189.1 million, with EPS of $2.64.
Strategic initiatives included board refreshment, a comprehensive operating model review, and increased share repurchase commitment following discussions with Elliott Management.
Financial highlights
Q2 2026 total revenues: $1,056.2 million (+4.3% Y/Y); Clear Aligner revenues: $870.9 million (+8.2% Y/Y); Systems & Services revenues: $185.3 million (-10.8% Y/Y).
Q2 2026 gross margin: 71.7% GAAP (72.3% non-GAAP), up 1.8 points year-over-year.
Q2 2026 GAAP operating margin: 14.6% (-1.5 pts Y/Y); non-GAAP operating margin: 22.9% (+1.6 pts Y/Y).
Q2 2026 GAAP EPS: $1.51 (down $0.20 Y/Y); non-GAAP EPS: $2.64 (+6% Y/Y).
Cash and cash equivalents totaled $1.1 billion as of June 30, 2026; free cash flow was $157.1 million.
Outlook and guidance
Q3 2026 revenues expected between $1.0–$1.02 billion, down sequentially; Clear Aligner volume up mid-single digits year-over-year, ASPs down sequentially.
Q3 2026 GAAP gross margin expected at 67.5%-68.5% due to one-time charges; non-GAAP gross margin at ~71%.
Full-year 2026 revenue growth expected at 3%-4% year-over-year; Clear Aligner volume growth at ~6%, ASP flat to slightly down; Systems & Services revenue down 6%-8%.
2026 GAAP operating margin expected at 15.1%-15.6%; non-GAAP operating margin at ~23%, up 100 bps year-over-year.
$400–$500 million in share repurchases planned for 2026; capital expenditures expected at $125–$150 million.
Latest events from Align Technology
- Product innovation and digital adoption drive global growth and margin expansion across key regions.ALGN
Leerink Global Healthcare Conference 2026 - Flexible pricing, new financing, and direct fab innovation drive growth amid mixed regional trends.ALGN
Baird Global Healthcare Conference 2025 - International growth, product innovation, and digital adoption drive double-digit gains and margin expansion.ALGN
Goldman Sachs 47th Annual Global Healthcare Conference 2026 - International growth, product innovation, and integration drive conversion and margin gains.ALGN
Jefferies Global Healthcare Conference 2026 - AI-powered digital workflows and 3D printing are transforming orthodontic care and patient engagement.ALGN
46th Annual William Blair Growth Stock Conference - Record Q4 and FY2025 results, robust Clear Aligner growth, and strong 2026 outlook.ALGN
Q4 2025 - Q2 2025 saw sequential revenue growth but year-over-year decline and major restructuring plans.ALGN
Q2 2025 - Clear Aligner volume up 6.2% YoY, revenue down 1.8%; margin, volume growth expected in 2025.ALGN
Q1 2025 - Record 2024 revenues and volumes set the stage for 2025 growth despite FX headwinds.ALGN
Q4 2024